Australian Pharmaceutical Patents Expiring March 2014

Below is a report from IP Organisers (an independent service company of Phillips Ormonde Fitzpatrick) detailing Australian Pharmaceutical Patents (that have been granted extensions) and that are due to expire in the coming month.

This report covers Australian patents whose Extension of Term expires in March 2014

  ip org


Australian Pharmaceutical Patents

Expiring March 2014



Active Ingredient

Tirofiban hydrochloride

Trade Name


Chemical Name

N-(butylsulfonyl)-O-[4-(4-piperidinyl)butyl]-L-tyrosine monohydrochloride monohydrate

Chemical Structure



Australian Patent


Expiry Date

16 March 2014

Patent Assignee

Correvio LLC


Novel sulfonamide fibrinogen receptor antagonists


A series of non-peptide derivatives of generic formula I that are antagonists of the fibrinogen IIb/IIIa receptor and thus are platelet anti-aggregation compounds useful in the prevention and treatment of diseases caused by thrombus formation.

Australian Register of Therapeutic Goods

ARTG ID 65161

ARTG ID 65162

Consumer Medicine Information

Aggrastat (Tirofiban hydrochloride)

Product Information

Aggrastat (Tirofiban hydrochloride)

For further information please contact Rodney Chiang-Cruise or Aaron McMillan at IP Organisers Pty Ltd